Rabbit polyclonal anti-ABCA1 (Cat# NB400-105) was from Novus Biologicals, Inc.
(Littleton, CO). Rat anti-mouse CD204 (scavenger receptor type I/II) monoclonal antibody was from AbD Serotec (Raleigh, NC). Rabbit Anti-actin (I-19) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA Binding and uptake of AcLDL: To determine receptor-specific binding and uptake, fluorescence-labeled acetylated LDL (Dil-AcLDL) was used as described (1) . Cells seeded on chamber slide (Nalge Nunc International) were treated with 10 ng/ml of IL10 for indicated time followed by incubation of Dil-AcLDL at 10 ug/ml in medium for 2 hr at 37°C. The media containing Dil-AcLDL was removed from culture and the cells were washed twice with probe-free media. The cells were visualized using standard rhodamine excitation:emission filter set. Fluorescence intensity was photographed using Nikon C1 Confocal System and quantified using Image J software.
Analysis of cellular cholesteryl ester contents and lipid accumulation: Macrophages
were treated with or without 10 ng/mL IL10 for 8 hr or 24 hr. The cellular cholesterol content was determined by the enzymatic, fluorometric method, using the Cholesterol Assay Kit from Cayman Chemical. Briefly, the cellular lipids were extracted with hexane/isopropanol (3/2, v/v), dried under a nitrogen flush, and then dissolved in isopropanol. For the determination of free cholesterol, the supernatant was added to enzyme mixtures containing cholesterol oxidase (2 U/mL). For the evaluation of total cholesterol, the supernatant was added to enzyme mixtures containing both cholesterol oxidase (2 U/mL) and cholesterol esterase (0.2 U/mL). The reaction mixtures for measuring free cholesterol and those for measuring total cholesterol were incubated at 37°C for 2 hours or 24 hours, respectively, followed by the addition of sodium hydroxide to terminate the reaction. Fluorescence intensity was measured using excitation at 540 nm and emission at 590 nm. The mass of cholesteryl ester was calculated by subtracting free cholesterol from total cholesterol. After lipid extraction, the cellular protein was dissolved in sodium hydroxide, and the protein concentration was determined.
Flow cytometry: To detect the role of IL10 in lipid accumulation and foam cell formation, immunofluorescence flow cytometric analysis was performed using BODIPY 493/503 (Cat# D-3922) as described (2) . In foam cell model 1, macrophages were treated with medium containing AcLDL (50 µg/ml) in the presence or absence of 10 ng/mL IL10 for 8 hr or 24 hr. In foam cell model 2, macrophages were laden with AcLDL (50 µg/ml) for 42 hr followed by IL10 treatment. The cells were washed with PBS and then scraped into 1 ml FACS buffer (PBS containing 0.1% BSA and 0.01% sodium azide). BODIPY stock (1 mg/ml in ethanol) was diluted to 10 µg/ml in PBS and was added directly to paraformadehyde-fixed cells. Cells were stained at room temperature for 20 minutes.
After washing extensively, stained cells were analyzed using a FACScan flow cytometer Cholesterol efflux: For apoAI-independent cholesterol efflux assay, efflux medium [DMEM/glutamine/0.2% FAFB, ± IL10 (10 ng/ml) with PGJ2 (5µM), or GW9662 (10 µM)] without apoAI was added in one set of wells. For apoAI-dependent cholesterol efflux assay, efflux medium mentioned above with 20 µg/ml of apoAI was added in another set of wells. After incubation for 2, 4, 6, 8 or 10 hr, 100 µl of media was removed and transferred to 1.5 ml Eppendorf tube. Cell debris was spun down at full speed for 5 min. The supernatant was gently transferred to 5 ml counting fluid to measure radioactivity as effluxed cholesterol. At the end of the experiment, 0.5 ml of 0.1 N NaOH was added to lyse the cells and incubated for 5 hr at room temperature. 100 µl of cell lysis was transferred to 5 ml counting fluid to measure radioactivity. ApoAI-induced [ 3 H]cholesterol efflux was measured as the fraction of total radiolabeled cholesterol appearing in the medium in the presence of apoAI after subtraction of values for apoAIfree medium. ApoAI-mediated efflux was determined using the following formula: (1) % efflux = efflux/total labeled cholesterol (2) apoAI specific efflux= % efflux (with apoAI) -% efflux (without apoAI) (3) % increase in apoAI mediated efflux = %(apoAI specific efflux)/ % efflux (without apoAI). 
